Conferoport 2 mg, harde capsules met verlengde afgifte

{
  "form": "Capsule met verlengde afgifte, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124874_smpc_en.pdf",
  "strength": null,
  "atc_label": "Tacrolimus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124874",
  "excipients": [
    "ALLURAROOD AC (E 129)",
    "ALLURAROOD AC ALUMINIUM LAK (E 129)",
    "BRILJANTBLAUW FCF (E 133)",
    "BRILJANTBLAUW FCF ALUMINIUMLAK (E133)",
    "ETHYLCELLULOSE (E 462)",
    "GELATINE (E 441)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 1-WATER",
    "LECITHINE, SOYA (E 322)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SIMETICON",
    "TARTRAZINE (E 102)",
    "TITAANDIOXIDE (E 171)",
    "ZONNEGEEL FCF (E 110)",
    "ZONNEGEEL FCF ALUMINIUMLAK (E 110)",
    "ZWARTE INKT"
  ],
  "substances": [
    "TACROLIMUS 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124874_piluk.pdf",
  "authorised_at": "2019/10/08",
  "procedure_number": "NL/H/4509/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "124874",
  "additional_monitoring": "N"
}